MASH Pathogenesis and Therapeutic Approaches 2025

Francisco has been the VP of Liver Disease at InSphero since 2021. He obtained a PhD in molecular biology at the Pasteur Institute in Paris. He has been trained for 6 years as a postdoctoral fellow at Harvard University/Dana Farber Cancer Institute and Karolinska Institute where he focused on the molecular basis of metabolic disorders. He was appointed Assistant Professor at the University of Zurich between 2016 and 2021 where he led a basic research group and has identified novel mechanisms of energy balance regulation.